|Bid||28.50 x 800|
|Ask||29.21 x 800|
|Day's Range||27.86 - 29.77|
|52 Week Range||11.51 - 49.50|
|Beta (5Y Monthly)||1.99|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In this article we will analyze whether TransMedics Group, Inc. (NASDAQ:TMDX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead […]
TransMedics (TMDX) delivered earnings and revenue surprises of -3.57% and 1.78%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
TransMedics is looking to disrupt an entire industry and help thousands of transplant patients in the U.S. in the process.